{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:39:15Z","timestamp":1775011155852,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013071","name":"Major Program of National Fund of Philosophy and Social Science of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ketogenic diet therapy (KDT), characterized by a high-fat, low-carbohydrate composition with adequate protein and other nutrients for growth, has emerged as an effective therapeutic approach for drug-resistant epilepsy. This study was designed to investigate the existing challenges in KDT implementation and evaluate its current utilization status within the Chinese healthcare context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From August 27 to September 5, 2024, a comprehensive questionnaire was disseminated to 418 epilepsy centers throughout China via the Commission on Standardized Development of Epilepsy Centers and the Commission on KDT, which operate under the auspices of the China Association Against Epilepsy (CAAE). The distribution leveraged both email and WeChat platforms to ensure broad reach and accessibility. The survey instrument encompassed five key domains: (1) baseline characteristics of surveyed epilepsy centers, (2) clinical application of KDT, (3) the efficacy of KDT: perspectives from epilepsy centers, (4) the adverse effects of KDT, and (5) implementation challenges and recommendations for KDT adoption. All the collected data were analyzed using descriptive statistical methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We received 258 completed questionnaires, for a response rate of 62%. Among the responding epilepsy centers, the classic KDT (cKDT) was utilized by 63% of the centers, the modified Atkins diet (MAD) was utilized by 40% of the centers, the low-glycemic-index treatment (LGIT) was utilized by 20% of the centers, and the medium-chain triglyceride (MCT) diet was utilized by 25% of the centers. The most significant barrier to KDT implementation was identified as limited KDT-related expertise among clinical practitioners, reported by 83% of the respondents. Additionally, improving patient and family education programs on KDT management was the most frequently cited factor (93%) for increasing KDT utilization. The data revealed strong clinical need for promoting KDT implementation, particularly in the management of super-refractory status epilepticus and refractory status epilepticus. Among the 120 epilepsy centers that implemented KDT, 27 reported cases of gastrointestinal adverse reactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study constitutes the first nationwide comprehensive investigation into the clinical application of KDT in China. The results reveal a notably limited adoption of KDT across epilepsy centers, despite its well-documented therapeutic efficacy and favorable safety profile. The current implementation remains limited to a select number of specialized centers and a relatively small patient population, primarily due to insufficient awareness and understanding among healthcare practitioners. These findings provide evidence-based insights that underscore the necessity for strategic initiatives to promote wider implementation of KDT in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42494-026-00242-w","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:29:58Z","timestamp":1775006998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of the implementation and utilization of ketogenic diet therapy in China"],"prefix":"10.1186","volume":"8","author":[{"given":"Wenjie","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-9710","authenticated-orcid":false,"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"12","key":"242_CR1","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1007\/s10072-020-04600-5","volume":"41","author":"P Pavone","year":"2020","unstructured":"Zarnowska IM. Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned. Nutrients. 2020;12(9):2616.\u00a0","journal-title":"Neurol Sci"},{"issue":"1","key":"242_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s42494-022-00089-x","volume":"4","author":"W Jiang","year":"2022","unstructured":"Jiang W, Liao J, Zhou D, Mu J. Ketogenic diet therapy for epilepsy: past 100 years of practice. Acta Epileptol. 2022;4(15).","journal-title":"Acta Epileptol"},{"key":"242_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109279","author":"FJP Teixeira","year":"2023","unstructured":"Teixeira FJP, Shannon J, Busl KM, Robinson CP, Ahmed B, Katz J, et al. Utilization of the ketogenic diet for adults with status epilepticus. Epilepsy Behav. 2023:144,109279.\u00a0","journal-title":"Epilepsy Behav"},{"issue":"8","key":"242_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1177\/08830738211004747","volume":"36","author":"S Sharma","year":"2021","unstructured":"Sharma S, Goel S, Kapoor D, Garg D, Panda I, Elwadhi A, et al. Evaluation of the Modified Atkins Diet for the Treatment of Epileptic Spasms Refractory to Hormonal Therapy: A Randomized Controlled Trial. J Child Neurol. 2021;36(8):686-691.\u00a0","journal-title":"J Child Neurol"},{"key":"242_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106574","volume":"171","author":"K Lakshminarayanan","year":"2021","unstructured":"Lakshminarayanan K, Agarawal A, Panda PK, Sinha R, Tripathi M, Pandey RM, et al. Efficacy of low glycemic index diet therapy (LGIT) in children aged 2-8 years with drug-resistant epilepsy: A randomized controlled trial. Epilepsy Res. 2021;171:106574.\u00a0","journal-title":"Epilepsy Res"},{"issue":"5","key":"242_CR6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","volume":"50","author":"EG Neal","year":"2009","unstructured":"Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009;50(5):1109-17.\u00a0","journal-title":"Epilepsia"},{"key":"242_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109315","volume":"146","author":"TY Hsieh","year":"2023","unstructured":"Hsieh TY, Su TY, Hung KY, Hsu MS, Lin YJ, Kuo HC, et al. Feasibility of ketogenic diet therapy variants for refractory epilepsy in neonates to infants under 2 years old. Epilepsy Behav. 2023;146:109315.\u00a0","journal-title":"Epilepsy Behav"},{"issue":"6","key":"242_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/epd2.20160","volume":"25","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li Y, Ni Y, Gong X, Lu Z, Zhou Y, et al. Long-term effectiveness and seizure recurrence risk factors of ketogenic diet for pediatric refractory epilepsy: Experience from a tertiary care center in China. Epileptic Disord. 2023;25(6):856-66.\u00a0","journal-title":"Epileptic Disord"},{"issue":"1","key":"242_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/a-1942-2447","volume":"54","author":"J Shen","year":"2023","unstructured":"Shen J, Jiang T, Gao F, Jiang K. Efficacy, Retention Rate, and Influencing Factors of Ketogenic Diet Therapy in Children with Refractory Epilepsy: A Retrospective Study. Neuropediatrics. 2023;54(1):37-43.\u00a0","journal-title":"Neuropediatrics"},{"key":"242_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2024.2336716","author":"JK Ballesteros Tapias","year":"2024","unstructured":"Ballesteros Tapias JK, Conde Hurtado DI, Casta\u00f1o LH, P\u00e9rez AM. Ketogenic diet therapies as a non-pharmacological adjuvant in resistant epilepsy: retrospective analysis of adult outpatients in Colombia. Nutr Neurosci. 2024;27(12):1363\u201369.","journal-title":"Nutr Neurosci"},{"issue":"4","key":"242_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1528-1167.2010.02941.x","volume":"52","author":"M Smith","year":"2011","unstructured":"Smith M, Politzer N, Macgarvie D, McAndrews MP, Del Campo M. Efficacy and tolerability of the modified Atkins diet in adults with pharmacoresistant epilepsy: a prospective observational study. Epilepsia. 2011;52(4):775-80.\u00a0","journal-title":"Epilepsia"},{"issue":"6","key":"242_CR12","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/s41390-023-02554-w","volume":"94","author":"AM El-Shafie","year":"2023","unstructured":"El-Shafie AM, Bahbah WA, Abd El Naby SA, Omar ZA, Basma EM, Hegazy AAA, et al. Impact of two ketogenic diet types in refractory childhood epilepsy. Pediatr Res. 2023;94(6):1978-89.\u00a0","journal-title":"Pediatr Res"},{"issue":"5","key":"242_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MPG.0000000000003928","volume":"77","author":"J Menzies","year":"2023","unstructured":"Menzies J, Sundararaj A, Cardamone M, McHarg A, Leach S, Krishnan U. Ketogenic Diets in Children With Intractable Epilepsy and its Effects on Gastrointestinal Function, Gut Microbiome, Inflammation, and Quality of Life. J Pediatr Gastroenterol Nutr. 2023;77(5):679-85.\u00a0","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"242_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091744","author":"S Perna","year":"2022","unstructured":"Perna S, Ferraris C, Guglielmetti M, Alalwan TA, Mahdi AM, Guido D, et al. Effects of classic ketogenic diet in children with refractory epilepsy: a retrospective cohort study in Kingdom of Bahrain. Nutrients. 2022;14(9):1744.","journal-title":"Nutrients"},{"issue":"1","key":"242_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/jhn.12697","volume":"33","author":"VJ Whiteley","year":"2019","unstructured":"Whiteley VJ, Martin-McGill KJ, Carroll JH, Taylor H, Schoeler NE; Ketogenic Dietitians Research Network (KDRN). Nice to know: impact of NICE guidelines on ketogenic diet services nationwide. J Hum Nutr Diet. 2020;33(1):98-105.\u00a0","journal-title":"J Hum Nutr Diet"},{"issue":"2","key":"242_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-277X.2010.01040.x","volume":"23","author":"KMG Lord","year":"2010","unstructured":"Lord, K & Magrath G.\u00a0Use of the ketogenic diet and dietary practices in the UK. J Hum Nutr Diet. 2010;23(2):126\u201332.","journal-title":"J Hum Nutr Diet"},{"issue":"7","key":"242_CR17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1177\/0883073814545115","volume":"30","author":"DE Jung","year":"2014","unstructured":"Jung DE, Joshi SM, Berg AT. How do you keto? Survey of North American Pediatric Ketogenic Diet Centers. J Child Neurol. 2015;30(7):868\u201373.","journal-title":"J Child Neurol"},{"key":"242_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.yebeh.2018.05.031","volume":"86","author":"B Dozi\u00e8res-Puyravel","year":"2018","unstructured":"Dozi\u00e8res-Puyravel B, Fran\u00e7ois L, de Lucia S, Goujon E, Danse M, Auvin S. Ketogenic diet therapies in France: state of the use in 2018. Epilepsy Behav. 2018;86:204\u20136.","journal-title":"Epilepsy Behav"},{"issue":"11","key":"242_CR19","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/epi.17058","volume":"62","author":"Y Lin","year":"2021","unstructured":"Lin Y, Hu S, Hao X, Duan L, Wang W, Zhou D, et al. Epilepsy centers in China: current status and ways forward. Epilepsia. 2021;62(11):2640\u201350.","journal-title":"Epilepsia"},{"issue":"2","key":"242_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/seiz.2000.0385","volume":"9","author":"GMA Magrath","year":"2000","unstructured":"Magrath G, MacDonald A, Whitehouse, W. Dietary practices and use of the ketogenic diet in the UK. Seizure. 2000;9(2):128\u201330.","journal-title":"Seizure"},{"issue":"12","key":"242_CR21","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S1474-4422(23)00370-8","volume":"22","author":"NE Schoeler","year":"2023","unstructured":"Schoeler NE, Marston L, Lyons L, Halsall S, Jain R, Titre-Johnson S, et al. Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial. Lancet Neurol. 2023;22(12):1113-24.\u00a0","journal-title":"Lancet Neurol"},{"issue":"2","key":"242_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1684\/epd.2021.1389","volume":"24","author":"S Kacker","year":"2022","unstructured":"Kacker S, Nordli DR Jr, Phitsanuwong C. Efficacy and tolerability of the modified Atkins diet in children with drug-resistant genetic generalized epilepsy. Epileptic Disord. 2022;24(2):295-301.\u00a0","journal-title":"Epileptic Disord"},{"issue":"4","key":"242_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/jhn.13324","volume":"37","author":"T Cameron","year":"2024","unstructured":"Cameron T, Allan K, Kay Cooper. The use of ketogenic diets in children living with drug-resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review. J Hum Nutr Diet. 2024;37(4):827-46.\u00a0","journal-title":"J Hum Nutr Diet"},{"key":"242_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.5648","author":"N Devi","year":"2023","unstructured":"Devi N, Madaan P, Kandoth N, Bansal D, Sahu JK. Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant Epilepsy: A Systematic Review and Network Meta-analysis. JAMA Pediatr. 2023;177(3):258-66.\u00a0","journal-title":"JAMA Pediatr"},{"issue":"4","key":"242_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/nutrit\/nuad071","volume":"82","author":"C D\u00edez-Arroyo","year":"2024","unstructured":"D\u00edez-Arroyo C, Garc\u00eda-Garc\u00eda M, Soto-M\u00e9ndez MJ, Molina-Montes E, Gil-Campos M, Gil \u00c1, et al. Effect of the ketogenic diet as a treatment for refractory epilepsy in children and adolescents: a systematic review of reviews. Nutr Rev. 2024;82(4):487-502.\u00a0","journal-title":"Nutr Rev"},{"issue":"1","key":"242_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/epi4.12836","volume":"9","author":"M Armeno","year":"2023","unstructured":"Armeno M, Calligaris S, Gagiulo D, Cresta A, Vaccarezza MM, Diez CG, et al. Use of ketogenic dietary therapy for drug-resistant epilepsy in early infancy. Epilepsia Open. 2024;9(1):138-49.\u00a0","journal-title":"Epilepsia Open"},{"key":"242_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10143028","author":"YS Alolayan","year":"2021","unstructured":"Alolayan YS, McKinley K, Bhatia R, Alkhachroum A. Review and Updates on the Treatment of Refractory and Super Refractory Status Epilepticus. J Clin Med. 2021;10(14):3028.\u00a0","journal-title":"J Clin Med"},{"key":"242_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s42494-021-00078-6","author":"X Tong","year":"2022","unstructured":"Tong X, Cai Q, Cao D, Yu L. Chinese expert recommendations on ketogenic diet therapy for super-refractory status epilepticus. Acta Epileptol. 2022;8(4).","journal-title":"Acta Epileptol"},{"issue":"11","key":"242_CR29","first-page":"820","volume":"57","author":"Neurology Group SoP","year":"2019","unstructured":"Subspecialty Group of Neurology, the Society of Pediatrics, Chinese Medical Association; China Association Against Epilepsy; Editorial Board, Chinese Journal of Pediatrics. Consensus on ketogenic diet therapy for epilepsy and related nervous system diseases. Zhonghua Er Ke Za Zhi. 2019;57(11):820-5. (in Chinese)\u00a0","journal-title":"Expert Consensus on the Application of Ketogenic Diet Therapy in Epilepsy and Related Neurological Disorders"},{"issue":"7","key":"242_CR30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.braindev.2016.01.002","volume":"38","author":"T Fujii","year":"2016","unstructured":"Fujii T, Ito Y, Takahashi S, Shimono K, Natsume J, Yanagihara K, et al. Outcome of ketogenic diets in GLUT1 deficiency syndrome in Japan: A nationwide survey. Brain Dev. 2016;38(7):628-37.\u00a0","journal-title":"Brain Dev"},{"issue":"2","key":"242_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","volume":"3","author":"EH Kossoff","year":"2018","unstructured":"Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175-92.\u00a0","journal-title":"Epilepsia Open"},{"key":"242_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060919","author":"J Karandien\u0117","year":"2024","unstructured":"Karandien\u0117 J, Endzinien\u0117 M, Liau\u0161ien\u0117 K, Jurkevi\u010dien\u0117 G. The Assessment of the Efficacy, Safety, and Challenges of Ketogenic Diet Therapy in Children with Epilepsy: The First Experience of a Single Center. Medicina (Kaunas). 2024;60(6):919.\u00a0","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"242_CR33","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/j.1528-1167.2005.00282.x","volume":"46","author":"AGCSJI Bergqvist","year":"2005","unstructured":"Bergqvist AG, Schall JI, Gallagher PR, Cnaan A, Stallings VA. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia. 2005;46(11):1810-9.\u00a0","journal-title":"Epilepsia"},{"key":"242_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109234","author":"I Erkent","year":"2023","unstructured":"Erkent I, Ilgaz F, Dericioglu N. Difficulties in the implementation of the ketogenic diet in adult patients with refractory epilepsy. Epilepsy Behav. 2023;144:109234.\u00a0","journal-title":"Epilepsy Behav"},{"key":"242_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.109791","author":"RS Stainman","year":"2024","unstructured":"Stainman RS, Turner Z, Kossoff EH. Changes in pediatric referrals after the 2009 ketogenic diet consensus recommendations. Epilepsy Behav. 2024;155:109791.","journal-title":"Epilepsy Behav"},{"key":"242_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/nu12102920","author":"L Pasca","year":"2020","unstructured":"Pasca L, Varesio C, Ferraris C, Guglielmetti M, Trentani C, Tagliabue A, et al. Families' Perception of Classic Ketogenic Diet Management in Acute Medical Conditions: A Web-Based Survey. Nutrients. 2020;12(10):2920.\u00a0","journal-title":"Nutrients"},{"key":"242_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/nu15041058","author":"FF Operto","year":"2023","unstructured":"Operto FF, Labate A, Aiello S, Perillo C, de Simone V, Rinaldi R, et al. The Ketogenic Diet in Children with Epilepsy: A Focus on Parental Stress and Family Compliance. Nutrients. 2023;15(4):1058.\u00a0","journal-title":"Nutrients"},{"issue":"4","key":"242_CR38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jpeds.2014.12.018","volume":"166","author":"C Wibisono","year":"2015","unstructured":"Wibisono C, Rowe N, Beavis E, Kepreotes H, Mackie FE, Lawson JA, et al. Ten-year single-center experience of the ketogenic diet: factors influencing efficacy, tolerability, and compliance. J Pediatr. 2015;166(4):1030-6.e1.\u00a0","journal-title":"J Pediatr"},{"key":"242_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nutres.2024.03.009","volume":"126","author":"LC Lopes Neri","year":"2024","unstructured":"Lopes Neri LC, Guglielmetti M, Fiorini S, Pasca L, Zanaboni MP, de Giorgis V, et al. Adherence to ketogenic dietary therapies in epilepsy: A systematic review of literature. Nutr Res. 2024;126:67-87.\u00a0","journal-title":"Nutrition research (New York, NY)"},{"issue":"14","key":"242_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1177\/0883073819866607","volume":"34","author":"C Fenton","year":"2019","unstructured":"Fenton C, Groveman S, Chee CM, Bergqvist AGC. Benefits of a Ketogenic Teaching Kitchen. J Child Neurol. 2019;34(14):886-90.\u00a0","journal-title":"J Child Neurol"},{"key":"242_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041240","author":"A-M Costa","year":"2021","unstructured":"Costa AM, Marchi\u00f2 M, Bruni G, Bernabei SM, Cavalieri S, Bondi M, et al. Evaluation of E-Health Applications for Paediatric Patients with Refractory Epilepsy and Maintained on Ketogenic Diet. Nutrients. 2021;13(4):1240.\u00a0","journal-title":"Nutrients"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-026-00242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-026-00242-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-026-00242-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:29:59Z","timestamp":1775006999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42494-026-00242-w"}},"subtitle":["For the Commission on\u00a0Standardized Development of Epilepsy Centers and Commission on Ketogenic Diet, China Association Against\u00a0Epilepsy"],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1186\/s42494-026-00242-w","relation":{},"ISSN":["2096-9384","2524-4434"],"issn-type":[{"value":"2096-9384","type":"print"},{"value":"2524-4434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Yuping Wang is the members of the Editorial Board for\n                      Acta Epileptologica\n                      , who was not involved in the journal\u2019s review of or decisions related to this manuscript. Other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}